Manashi Priyadarshini

Employment

• The University of Texas MD Anderson Cancer Center Post doctoral Fellow
  2023 - Present

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (4)

• CRISPR-based kinome-screening revealed MINK1 as a druggable player to rewire 5FU-resistance in OSCC through AKT/MDM2/p53 axis.
  Oncogene 2022 DOI: 10.1038/s41388-022-02475-8
  +Save
• SARI inhibits growth and reduces survival of oral squamous cell carcinomas (OSCC) by inducing endoplasmic reticulum stress.
  Life sciences 2021 DOI: 10.1016/j.lfs.2021.120141
  +Save
• DDX3 modulates cisplatin resistance in OSCC through ALKBH5-mediated m6A-demethylation of FOXM1 and NANOG.
  Apoptosis : an international journal on programmed cell death 2020 DOI: 10.1007/s10495-020-01591-8
  +Save
• STAT3- and GSK3β-mediated Mcl-1 regulation modulates TPF resistance in oral squamous cell carcinoma.
  Carcinogenesis 2019 DOI: 10.1093/carcin/bgy135
  +Save